PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 10:26 AM ET

Sponsor Check › Person

MK
No photo found yet (own website and image search run after this page is viewed)

Maha Katabi

Named as an officer, director or promoter on SEC Form D filings · CA · Feb 22, 2016 → Jun 24, 2026

8deals (issuers)
$1.59Breported sold
248investors
15Form D filings
2016–2026years on file
Follow this personLook further ↓PDF

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:17 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Maha Katabi is listed as an executive officer and director on 15 SEC Form D filings by 8 issuers between Feb 2016 and Jun 2026. Largest by amount reported sold: Sofinnova Venture Partners XII, L.P. (Menlo Park, CA — pooled investment fund — 2024–2026; $527.1M reported sold to 78 investors), Sofinnova Venture Partners XI, L.P. (Menlo Park, CA — pooled investment fund — 2021–2023; $500M reported sold to 50 investors), RayzeBio, Inc. (San Diego, CA — biotechnology — 2022; $167.9M reported sold to 23 investors), Star Therapeutics LLC (South San Francisco, CA — industry reported as "Other" — 2025; $125M reported sold to 21 investors), Quanta Therapeutics, Inc. (South San Francisco, CA — biotechnology — 2021–2026; $76.2M reported sold to 17 investors) and 3 more (all listed below).

What this means A repeat sponsor — 8 separate companies raised money with this person listed as executive officer and director, over about 10 years. Across those companies the filings report $1.59B sold in total.

Listed alongside James Healy (6 shared filings), Cameron Pitt (4 shared filings), Maria Fardis (4 shared filings), Perry Nisen (4 shared filings), Arjun Goyal (3 shared filings) and 50 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Maha. Each name links to their own page.

The issuers belong to 2 sponsor groups: Sofinnova Venture (9 issuers, $2.76B reported sold, 2011–2026) and Cerimon (3 issuers, $137.2M reported sold, 2009–2025).

What this means This person is listed across more than one sponsor team; each group page shows that team's full track record.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CO, CT, DC, DE, FINRA, FL, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, WA, WI, WV, WY) — none found.

What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.

We compared 15 public filings for Maha Katabi and found 15 differences, 4 worth asking the sponsor about: Paid seller listed without a CRD number: Citibank, N.A; Paid seller listed without a CRD number: Gencap Global Advisors DMCC; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Maha Katabi has not run yet — it is joining a line of 54,116 names; searches run around the clock at the hosts' allowed rate. Searched so far: 641 names.

Community comments are quoted as written by their authors. Sources searched: Bing (site:reddit.com / site:biggerpockets.com) and Reddit's own search, plus DuckDuckGo/Brave/BiggerPockets search when they are answering.

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:17 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: 48 regulators (FINRA, NASAA, 37 states) — crawled Oct 24, 2026, 8:48 AM ET

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Maha Katabi..

State securities regulators: Securities regulators searched (64,910 actions): FINRA (38,350 actions, 1995–2026), NASAA (31 actions, 2000–2026; listing starts 1997), AK Division of Banking and Securities (273 actions, 1971–2025), AL Securities Commission (880 actions, 2001–2026), AR Securities Department (1,305 actions, 1998–2026), AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002 — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), CO Division of Securities (731 actions, 2001–2026; older years from the Internet Archive (snapshot of 2026-05-02)), CT Department of Banking Securities Division (940 actions, 2006–2026; older years from the Internet Archive (snapshot of 2026-04-22)), DC DISB Securities Bureau (25 actions, 2012–2026), DE DOJ Investor Protection Unit (257 actions, 1987–2026), FL Office of Financial Regulation (49 actions, 2018–2026), GA Secretary of State Securities Division (65 actions, 2015–2026; listing starts 2012), HI DCCA Securities Enforcement Branch (26 actions, 2012–2026), ID Department of Finance Securities Bureau (663 actions, 1994–2026), IL Secretary of State Securities Department (4,122 actions, 2003–2023), KS Insurance Department Securities Division (58 actions), KY Department of Financial Institutions (342 actions, 2005–2026), LA Office of Financial Institutions Securities Division (13 actions, 2010–2025; listing starts 2008), MA Secretary of the Commonwealth Securities Division (125 actions, 2012–2025; live site blocks automated access — loaded from the Internet Archive snapshot of 2026-02-04), MD Attorney General Securities Division (1,054 actions, 2004–2026), ME Office of Securities (539 actions, 2000–2026), MI LARA Corporations, Securities & Commercial Licensing Bureau (201 actions), MO Secretary of State Securities Division (919 actions, 1998–2026), MS Secretary of State Securities Division (209 actions, 1995–2026), MT Commissioner of Securities and Insurance (597 actions, 2000–2026), NC Secretary of State Securities Division (265 actions, 2004–2024), ND Securities Department (711 actions, 1990–2026; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2026-01-06), NH Bureau of Securities Regulation (402 actions, 2002–2026), NM Regulation and Licensing Department Securities Division (90 actions, 2010–2025), NV Secretary of State Securities Division (118 actions, 2018–2026), NY Attorney General Investor Protection Bureau (44 actions, 2012–2026), OH Division of Securities (327 actions, 1993–2006), OK Department of Securities (2,531 actions, 1998–2026), OR Division of Financial Regulation (589 actions, 1988–2026), PA Department of Banking and Securities (1,448 actions, 2008–2024; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2024-08-09), RI DBR Securities Division (98 actions, 2005–2025), SC Attorney General Securities Division (540 actions, 2006–2026), SD Division of Insurance – Securities Regulation (106 actions, 2017–2026), TN Department of Commerce and Insurance Securities Division (405 actions, 1992–2026), TX State Securities Board (936 actions, 1999–2026), UT Division of Securities (772 actions, 2000–2026; older years from the Internet Archive (snapshot of 2010-05-27)), VT DFR Securities Division (137 actions, 2010–2026), WA DFI (2,039 actions, 2001–2026), WI DFI Division of Securities (1,072 actions, 1998–2026), WV Securities Commission (State Auditor) (64 actions), WY Secretary of State Compliance Division (6 actions, 2016–2024) — last crawled Oct 24, 2026, 8:48 AM ET. No machine-readable public listing today for IA, IN, MN, NE, NJ, VA (see docs/state-regulators.md).

3. Bankruptcies

None found in sources searched — federal bankruptcy courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:17 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

15 differences found between the filings for Maha Katabi — 4 worth asking about (compared 15 filings on Oct 24, 2026)

Note · Nov 18, 1999 – Feb 14, 2000

Bankruptcy case: First USA Bank, N.A. v. Seidenberg — filed Nov 18, 1999

United States Bankruptcy Court, N.D. California docket "First USA Bank, N.A. v. Seidenberg" filed Nov 18, 1999, closed Feb 14, 2000. Beth Seidenberg (listed on the same filings) is listed as Defendant ("Seidenberg"). Our match estimate: 70%.

What this means A bankruptcy filing was found. Many are old or personal and have nothing to do with the deal — but ask what it was and when it closed.

Docket · United States Bankruptcy Court, N.D. California ↗Beth Seidenberg — PartnerFacts page ↗
Sources
Note · Jun 24, 2024

Maha Katabi appears on 1 deal that stopped filing before reaching its target

Marea Therapeutics, Inc. (last filing Jun 24, 2024; $65,418,629 sold of $160,418,629). Each has no filing in more than two years and reported under half its target sold.

What this means An issuer whose last filing is more than two years old and reported under half its target sold. The raise may have closed early or quietly stopped. Ask what happened to each.

Marea Therapeutics, Inc. — PartnerFacts page ↗
Sources
Worth asking · Aug 15, 2025 – Jun 22, 2026

Paid seller listed without a CRD number: Citibank, N.A. — Sofinnova Venture Partners XII, L.P.

Citibank, N.A. is listed as receiving sales compensation on 2 filings (Aug 15, 2025 to Jun 22, 2026) with no FINRA CRD number given.

What this means People paid to sell securities normally hold a FINRA registration with a CRD number. Without one we cannot look them up on BrokerCheck. Ask who they are and whether they are registered.

Form D/A · Jun 22, 2026 ↗BrokerCheck search: Citibank, N.A. ↗Sofinnova Venture Partners XII, L.P. — PartnerFacts page ↗
Sources
Worth asking · Feb 22, 2022 – Sep 11, 2023

Paid seller listed without a CRD number: Citibank, N.A. — Sofinnova Venture Partners XI, L.P.

Citibank, N.A. is listed as receiving sales compensation on 2 filings (Feb 22, 2022 to Sep 11, 2023) with no FINRA CRD number given.

What this means People paid to sell securities normally hold a FINRA registration with a CRD number. Without one we cannot look them up on BrokerCheck. Ask who they are and whether they are registered.

Form D/A · Sep 11, 2023 ↗BrokerCheck search: Citibank, N.A. ↗Sofinnova Venture Partners XI, L.P. — PartnerFacts page ↗
Sources
Worth asking · Sep 10, 2021

Paid seller listed without a CRD number: Gencap Global Advisors DMCC — Sofinnova Venture Partners XI, L.P.

Gencap Global Advisors DMCC is listed as receiving sales compensation on 1 filing (Sep 10, 2021) with no FINRA CRD number given.

What this means People paid to sell securities normally hold a FINRA registration with a CRD number. Without one we cannot look them up on BrokerCheck. Ask who they are and whether they are registered.

Form D · Sep 10, 2021 ↗BrokerCheck search: Gencap Global Advisors DMCC ↗Sofinnova Venture Partners XI, L.P. — PartnerFacts page ↗
Sources
Worth asking · Oct 29, 2020 – Feb 25, 2021

Form D filed 119 days after the first sale — Vera Therapeutics, Inc.

The filing says the first sale was Oct 29, 2020. The Form D was filed Feb 25, 2021 — 119 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 104 days past that.

What this means A late notice is common and carries no penalty by itself. It is worth asking the sponsor why the paperwork lagged.

Form D · Feb 25, 2021 ↗Vera Therapeutics, Inc. — PartnerFacts page ↗
Sources
Note · Aug 25, 2022 – Sep 22, 2022

Form D filed 28 days after the first sale — RayzeBio, Inc.

The filing says the first sale was Aug 25, 2022. The Form D was filed Sep 22, 2022 — 28 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 13 days past that.

What this means A late notice is common and carries no penalty by itself. It is worth asking the sponsor why the paperwork lagged.

Form D · Sep 22, 2022 ↗RayzeBio, Inc. — PartnerFacts page ↗
Sources
Note · Jun 11, 2024 – Jun 24, 2024

No amendment in the last 12 months on an offering that may still be open — Marea Therapeutics, Inc. (latest filing Jun 24, 2024)

The latest filing for this offering is dated Jun 24, 2024 (first sale Jun 11, 2024). It reports $65,418,629 sold of $160,418,629 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Form D · Jun 24, 2024 ↗Marea Therapeutics, Inc. — PartnerFacts page ↗
Sources
Note · Oct 20, 2021 – Nov 3, 2021

No amendment in the last 12 months on an offering that may still be open — Quanta Therapeutics, Inc. (latest filing Nov 3, 2021)

The latest filing for this offering is dated Nov 3, 2021 (first sale Oct 20, 2021). It reports $40,152,323 sold of $70,152,314 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Form D · Nov 3, 2021 ↗Quanta Therapeutics, Inc. — PartnerFacts page ↗
Sources
Note · May 25, 2023 – Jun 24, 2026

Offering amount changed between filings — Quanta Therapeutics, Inc.

The May 25, 2023 filing says $54,999,988 offered; the Jun 24, 2026 Form D/A says $89,098,282.

What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.

Form D (earlier) · May 25, 2023 ↗Form D/A (later) · Jun 24, 2026 ↗Quanta Therapeutics, Inc. — PartnerFacts page ↗
Sources
Note · Feb 22, 2022 – Sep 11, 2023

Offering amount lowered between filings — Sofinnova Venture Partners XI, L.P.

The Feb 22, 2022 filing says $600,000,000 offered; the Sep 11, 2023 Form D/A says $500,000,000.

What this means The target raise got smaller. That can mean the plan shrank or the sponsor stopped early. Ask what changed in the deal.

Form D/A (earlier) · Feb 22, 2022 ↗Form D/A (later) · Sep 11, 2023 ↗Sofinnova Venture Partners XI, L.P. — PartnerFacts page ↗
Sources
Note · Dec 23, 2015 – Feb 22, 2016

Offering amount changed between filings — EFFECTOR THERAPEUTICS, INC.

The Dec 23, 2015 filing says $45,000,005 offered; the Feb 22, 2016 Form D/A says $56,000,005.

What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.

Form D (earlier) · Dec 23, 2015 ↗Form D/A (later) · Feb 22, 2016 ↗EFFECTOR THERAPEUTICS, INC. — PartnerFacts page ↗
Sources
Note · Apr 15, 2021

Same name, different state: "Maha Katabi" (X0) is a separate record

This page covers filings where the address state is CA. A separate record, "Maha Katabi" with address state X0, is listed on 1 filing — most recently by Gyroscope Therapeutics Ltd (Apr 15, 2021). Both records have filings in the same period (Apr 15, 2021).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Maha Katabi (X0) — PartnerFacts page ↗Form D · Apr 15, 2021 ↗Gyroscope Therapeutics Ltd — PartnerFacts page ↗Maha Katabi (CA) — this page ↗
Sources
Note · Aug 14, 2020

Same name, different state: "Maha Katabi" (MA) is a separate record

This page covers filings where the address state is CA. A separate record, "Maha Katabi" with address state MA, is listed on 1 filing — most recently by Aerovate Therapeutics, Inc. (Aug 14, 2020). Both records have filings in the same period (Aug 14, 2020).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Maha Katabi (MA) — PartnerFacts page ↗Form D · Aug 14, 2020 ↗Aerovate Therapeutics, Inc. — PartnerFacts page ↗Maha Katabi (CA) — this page ↗
Sources
Note · Aug 17, 2017

Same name, different state: "Maha Katabi" (KY) is a separate record

This page covers filings where the address state is CA. A separate record, "Maha Katabi" with address state KY, is listed on 1 filing — most recently by Apellis Pharmaceuticals, Inc. (Aug 17, 2017). Both records have filings in the same period (Aug 17, 2017).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Maha Katabi (KY) — PartnerFacts page ↗Form D · Aug 17, 2017 ↗Apellis Pharmaceuticals, Inc. — PartnerFacts page ↗Maha Katabi (CA) — this page ↗
Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

2 of 10 offerings report sales commissions totalling $4,836,319; 0 report finder's fees; 0 report proceeds to related persons. (includes amounts the issuer reported as estimates)

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Jun 24, 2026 D/A
Quanta Therapeutics, Inc.
File 021-482575
$0$0$0None listed on this filingEDGAR ↗
Jun 22, 2026 D/A
Sofinnova Venture Partners XII, L.P.
File 021-532792
$1,966,594 (est.)$0$0Citi Private Alternatives, LLC BrokerCheck CRD 153777 ↗
Citigroup Global Markets Inc. BrokerCheck CRD 7059 ↗
Citibank, N.A. no CRD number reported		EDGAR ↗
Oct 6, 2025 D
Star Therapeutics LLC
File 021-559890
$0$0$0None listed on this filingEDGAR ↗
Jun 24, 2024 D
Marea Therapeutics, Inc.
File 021-516752
$0$0$0None listed on this filingEDGAR ↗
Sep 11, 2023 D/A
Sofinnova Venture Partners XI, L.P.
File 021-412971
$2,869,725 (est.)$0$0Citi Private Advisory, LLC BrokerCheck CRD 153777 ↗
Citigroup Global Markets Inc. BrokerCheck CRD 7059 ↗
Citibank, N.A. no CRD number reported		EDGAR ↗
Feb 17, 2023 D
Quanta Therapeutics, Inc.
File 021-473779
$0$0$0None listed on this filingEDGAR ↗
Sep 22, 2022 D
RayzeBio, Inc.
File 021-459654
$0$0$0None listed on this filingEDGAR ↗
Nov 3, 2021 D
Quanta Therapeutics, Inc.
File 021-419719
$0$0$0None listed on this filingEDGAR ↗
Feb 25, 2021 D
Vera Therapeutics, Inc.
File 021-390559
$0$0$0None listed on this filingEDGAR ↗
Feb 22, 2016 D/A
EFFECTOR THERAPEUTICS, INC.
File 021-253725
$0$0$0None listed on this filingEDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 8

Every issuer that named Maha Katabi on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

QT
Biotechnology

Quanta Therapeutics, Inc.

South San Francisco, CA · Nov 3, 2021 → Jun 24, 2026 · 4 filings
  • Jun 24, 2026 · D/A · $76,192,272 sold of $89,098,282 · 17 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 25, 2023 · D · $50,685,368 sold of $54,999,988 · 13 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 17, 2023 · D · $29,999,993 sold of $29,999,993 · 9 investors · min. No minimum reported · role: Director EDGAR ↗
  • Nov 3, 2021 · D · $40,152,323 sold of $70,152,314 · 10 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $76.2M from 17 investors (86% of the $89.1M target) as of the latest filing. Maha is listed as director on 4 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

SV
Pooled Investment Fund · group: Sofinnova Venture

Sofinnova Venture Partners XII, L.P.

Menlo Park, CA · Dec 19, 2024 → Jun 22, 2026 · 3 filings
  • Jun 22, 2026 · D/A · $527,068,878 sold of $550,000,000 · 78 investors · min. No minimum reported · role: Executive Officer (Managing Member of the GP of the GP) EDGAR ↗
  • Aug 15, 2025 · D/A · $500,028,061 sold of $550,000,000 · 74 investors · min. No minimum reported · role: Executive Officer (Managing Member of the GP of the GP) EDGAR ↗
  • Dec 19, 2024 · D · $0 sold of $550,000,000 · 0 investors · min. No minimum reported · role: Executive Officer (Managing Member of the GP of the GP) EDGAR ↗

Raised $527.1M from 78 investors (96% of the $550M target) as of the latest filing. Maha is listed as executive officer on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(c) (8,096 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

ST
Other · group: Cerimon

Star Therapeutics LLC

South San Francisco, CA · Oct 6, 2025
  • Oct 6, 2025 · D · $124,999,974 sold of $124,999,974 · 21 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $125M from 21 investors (100% of the $125M target) as of the latest filing. Maha is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other / 506(b) (18,678 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

MT
Biotechnology

Marea Therapeutics, Inc.

San Francisco, CA · Jun 24, 2024
  • Jun 24, 2024 · D · $65,418,629 sold of $160,418,629 · 10 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $65.4M from 10 investors (41% of the $160.4M target) as of the latest filing. Maha is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

SV
Pooled Investment Fund · group: Sofinnova Venture

Sofinnova Venture Partners XI, L.P.

Menlo Park, CA · Sep 10, 2021 → Sep 11, 2023 · 3 filings
  • Sep 11, 2023 · D/A · $500,000,000 sold of $500,000,000 · 50 investors · min. No minimum reported · role: Executive Officer (Managing Member of the GP of the GP) EDGAR ↗
  • Feb 22, 2022 · D/A · $485,729,591 sold of $600,000,000 · 44 investors · min. No minimum reported · role: Executive Officer (Managing Member of the GP of the GP) EDGAR ↗
  • Sep 10, 2021 · D · $0 sold of $600,000,000 · 0 investors · min. No minimum reported · role: Executive Officer (Managing Member of the GP of the GP) EDGAR ↗

Raised $500M from 50 investors (100% of the $500M target) as of the latest filing. Maha is listed as executive officer on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

R
Biotechnology

RayzeBio, Inc.

San Diego, CA · Sep 22, 2022
  • Sep 22, 2022 · D · $167,901,481 sold of $167,901,481 · 18 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $167.9M from 23 investors (100% of the $167.9M target) as of the latest filing. Maha is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

VT
Biotechnology

Vera Therapeutics, Inc.

South San Francisco, CA · Feb 25, 2021
  • Feb 25, 2021 · D · $70,736,334 sold of $70,736,334 · 23 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $70.7M from 23 investors (100% of the $70.7M target) as of the latest filing. Maha is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

ET
Biotechnology

EFFECTOR THERAPEUTICS, INC.

San Diego, CA · Feb 22, 2016
  • Feb 22, 2016 · D/A · $56,000,005 sold of $56,000,005 · 20 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $56M from 26 investors (100% of the $56M target) as of the latest filing. Maha is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Other pages with the same name (3)

Separate person records under the same name, not combined with this page. Each line says whether it shares an issuer with this record.

  • Maha Katabi — KY, 1 issuer, Aug 17, 2017 → Aug 17, 2017 · no shared issuer
  • Maha Katabi — MA, 1 issuer, Aug 14, 2020 → Aug 14, 2020 · no shared issuer
  • Maha Katabi — United Kingdom (as filed: X0), 1 issuer, Apr 15, 2021 → Apr 15, 2021 · no shared issuer

People around Maha 40

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET. Showing the 40 with the most shared filings.

JH
No photo found yet (own website and image search run after this page is viewed)
Person

James Healy

Executive Officer · 6 shared filings (2 issuers) · also on 16 other issuers

James Healy is on 18 issuers in total — a repeat sponsor. Their page lists every one.

CP
No photo found yet (own website and image search run after this page is viewed)
Person

Cameron Pitt

Director, Executive Officer · 4 shared filings (1 issuer)

Listed on the same filings as Maha Katabi. Their page shows their other deals.

PN
No photo found yet (own website and image search run after this page is viewed)
Person

Perry Nisen

Executive Officer, Director · 4 shared filings (1 issuer)

Listed on the same filings as Maha Katabi. Their page shows their other deals.

MF
No photo found yet (own website and image search run after this page is viewed)
Person

Maria Fardis

Director · 4 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Maha Katabi. Their page shows their other deals.

SS
No photo found yet (own website and image search run after this page is viewed)
Person

Samuel Saks

Director · 3 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Maha Katabi. Their page shows their other deals.

AG
No photo found yet (own website and image search run after this page is viewed)
Person

Arjun Goyal

Director · 3 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Maha Katabi. Their page shows their other deals.

YH
No photo found yet (own website and image search run after this page is viewed)
Person

Ying Huang

Director · 3 shared filings (1 issuer)

Listed on the same filings as Maha Katabi. Their page shows their other deals.

BS
No photo found yet (own website and image search run after this page is viewed)
Person

Beth Seidenberg

Director · 2 shared filings (2 issuers) · also on 27 other issuers

Beth Seidenberg is on 29 issuers in total — a repeat sponsor. Their page lists every one.

AR
No photo found yet (own website and image search run after this page is viewed)
Person

Aaron Royston

Director · 2 shared filings (2 issuers) · also on 7 other issuers

Aaron Royston is on 9 issuers in total — a repeat sponsor. Their page lists every one.

SB
No photo found yet (own website and image search run after this page is viewed)
Person

Sarah Bhagat

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Maha Katabi. Their page shows their other deals.

LF
No photo found yet (own website and image search run after this page is viewed)
Person

Leonardo Faoro

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Maha Katabi. Their page shows their other deals.

CG
No photo found yet (own website and image search run after this page is viewed)
Person

Carl L. Gordon

Director · 1 shared filing (1 issuer) · also on 61 other issuers

Carl L. Gordon is on 62 issuers in total — a repeat sponsor. Their page lists every one.

JR
No photo found yet (own website and image search run after this page is viewed)
Person

Jonathan Root

Director · 1 shared filing (1 issuer) · also on 18 other issuers

Jonathan Root is on 19 issuers in total — a repeat sponsor. Their page lists every one.

MT
No photo found yet (own website and image search run after this page is viewed)
Person

Mary Tagliaferri

Director · 1 shared filing (1 issuer) · also on 2 other issuers

Listed on the same filings as Maha Katabi. Their page shows their other deals.

KE
No photo found yet (own website and image search run after this page is viewed)
Person

Kurt von Emster

Director · 1 shared filing (1 issuer) · also on 12 other issuers

Kurt von Emster is on 13 issuers in total — a repeat sponsor. Their page lists every one.

PE
No photo found yet (own website and image search run after this page is viewed)
Person

Patrick Enright

Director · 1 shared filing (1 issuer) · also on 15 other issuers

Patrick Enright is on 16 issuers in total — a repeat sponsor. Their page lists every one.

MF
No photo found yet (own website and image search run after this page is viewed)
Person

Matthew Fust

Director · 1 shared filing (1 issuer) · also on 5 other issuers

Matthew Fust is on 6 issuers in total — a repeat sponsor. Their page lists every one.

SG
No photo found yet (own website and image search run after this page is viewed)
Person

Simeon George

Director · 1 shared filing (1 issuer) · also on 32 other issuers

Simeon George is on 33 issuers in total — a repeat sponsor. Their page lists every one.

NS
No photo found yet (own website and image search run after this page is viewed)
Person

Nancy Stagliano

Director · 1 shared filing (1 issuer) · also on 3 other issuers

Listed on the same filings as Maha Katabi. Their page shows their other deals.

MC
No photo found yet (own website and image search run after this page is viewed)
Person

Michelle Carpenter

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Maha Katabi. Their page shows their other deals.

AN
No photo found yet (own website and image search run after this page is viewed)
Person

Amrit Nagpal

Director · 1 shared filing (1 issuer) · also on 7 other issuers

Amrit Nagpal is on 8 issuers in total — a repeat sponsor. Their page lists every one.

SP
No photo found yet (own website and image search run after this page is viewed)
Person

Sandip Panicker

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Maha Katabi. Their page shows their other deals.

SR
No photo found yet (own website and image search run after this page is viewed)
Person

Scott Robertson

Executive Officer · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Maha Katabi. Their page shows their other deals.

AR
No photo found yet (own website and image search run after this page is viewed)
Person

Adam Rosenthal

Executive Officer, Director · 1 shared filing (1 issuer)

Listed on the same filings as Maha Katabi. Their page shows their other deals.

GP
No photo found yet (own website and image search run after this page is viewed)
Person

Gary Patou

Executive Officer · 1 shared filing (1 issuer) · also on 4 other issuers

Gary Patou is on 5 issuers in total — a repeat sponsor. Their page lists every one.

AM
No photo found yet (own website and image search run after this page is viewed)
Person

Alana McNulty

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Maha Katabi. Their page shows their other deals.

MG
No photo found (searched own website, image search on Oct 24, 2026)
Person

Markus Goebel

Director · 1 shared filing (1 issuer) · also on 3 other issuers

Listed on the same filings as Maha Katabi. Their page shows their other deals.

KH
No photo found yet (own website and image search run after this page is viewed)
Person

Ken Haas

Director · 1 shared filing (1 issuer) · also on 5 other issuers

Ken Haas is on 6 issuers in total — a repeat sponsor. Their page lists every one.

LL
No photo found yet (own website and image search run after this page is viewed)
Person

Laurence Lasky

Director · 1 shared filing (1 issuer) · also on 3 other issuers

Listed on the same filings as Maha Katabi. Their page shows their other deals.

AY
No photo found yet (own website and image search run after this page is viewed)
Person

Angie You

Director · 1 shared filing (1 issuer) · also on 3 other issuers

Listed on the same filings as Maha Katabi. Their page shows their other deals.

SD
No photo found yet (own website and image search run after this page is viewed)
Person

Stephen T. Worland, Ph.D.

Executive Officer, Director · 1 shared filing (1 issuer)

Listed on the same filings as Maha Katabi. Their page shows their other deals.

AR
No photo found yet (own website and image search run after this page is viewed)
Person

Alex Rosen

Director · 1 shared filing (1 issuer) · also on 2 other issuers

Listed on the same filings as Maha Katabi. Their page shows their other deals.

JD
No photo found yet (own website and image search run after this page is viewed)
Person

Jerel Davis

Director · 1 shared filing (1 issuer) · also on 22 other issuers

Jerel Davis is on 23 issuers in total — a repeat sponsor. Their page lists every one.

DM
No photo found yet (own website and image search run after this page is viewed)
Person

David Maki

Director · 1 shared filing (1 issuer)

Listed on the same filings as Maha Katabi. Their page shows their other deals.

KS
No photo found yet (own website and image search run after this page is viewed)
Person

Ken Song

Executive Officer, Director · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Maha Katabi. Their page shows their other deals.

SM
No photo found yet (own website and image search run after this page is viewed)
Person

Scott Morrison

Director · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Maha Katabi. Their page shows their other deals.

CG
No photo found yet (own website and image search run after this page is viewed)
Person

Chris Garabedian

Director · 1 shared filing (1 issuer) · also on 11 other issuers

Chris Garabedian is on 12 issuers in total — a repeat sponsor. Their page lists every one.

AK
No photo found yet (own website and image search run after this page is viewed)
Person

Aaron Kantoff

Director · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Maha Katabi. Their page shows their other deals.

AC
No photo found yet (own website and image search run after this page is viewed)
Person

Andrew Cheng

Director · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Maha Katabi. Their page shows their other deals.

JT
No photo found yet (own website and image search run after this page is viewed)
Person

Jeff Tong

Director · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Maha Katabi. Their page shows their other deals.

The team behind the deals

SV
Sponsor group

Sofinnova Venture

9 issuers · 34 filings · $2.76B reported sold · 2011–2026

One team, 9 deal companies. Maha Katabi is listed on 2 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Maha Katabi.

C
Sponsor group

Cerimon

3 issuers · 9 filings · $137.2M reported sold · 2009–2025

One team, 3 deal companies. Maha Katabi is listed on 1 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Maha Katabi.

Same business address

51 other issuers file from the same address (first 50 shown)

A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.

Registrations and other filings

Business registration (state registry / Secretary of State)

Individuals are not matched to business registrations — registries list companies, and a name alone is not enough to tie a person to one. Officers and managers appear by name inside each matched company's record on the issuer pages. Registries searched: AL (Alabama Secretary of State — Business Entity Records (arc-sos.state.al.us), searched by issuer name, data as of Oct 24, 2026); CO (Colorado Secretary of State — Business Entities in Colorado (data.colorado.gov), data as of Oct 23, 2026); CT (Connecticut Secretary of the State — Business Registry (data.ct.gov), data as of Oct 24, 2026); FL (Florida Department of State, Division of Corporations — quarterly corporate data file (Sunbiz), data as of Oct 7, 2026); NY (New York Department of State — Corporations and Other Entities (data.ny.gov: All Filings + Active Corporations), data as of Oct 20, 2026); OR (Oregon Secretary of State — Active Businesses, All (data.oregon.gov), data as of Oct 20, 2026); PA (Pennsylvania Department of State — Registered Businesses, Current (data.pa.gov), data as of Oct 6, 2026); TX (Texas Comptroller — Active Franchise Taxpayers incl. Secretary of State file data (data.texas.gov), data as of Oct 24, 2026). Registries of other states have not been searched: many publish no bulk file and require a CAPTCHA or bot challenge on their search page, which we do not bypass (Delaware, for example, offers no public bulk file).

Adviser registration (Form ADV)

None of the 8 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Maha Katabi by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 8 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Maha Katabi is listed on: none on file. No website or social profile named in RayzeBio, Inc.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #144,267 of 374,652 in line (1,386 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (San Diego, CA). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Social and web

LinkedIn people search ↗Instagram ↗X (Twitter) ↗Facebook ↗YouTube ↗Google ↗Google Images ↗Google News ↗Meta Ad Library ↗

Courts

CourtListener / RECAP (federal) ↗PACER case locator (federal, login) ↗California — find the county court ↗Los Angeles Superior Court case search ↗

Securities regulators

SEC EDGAR full-text search ↗SEC action look-up ↗FINRA BrokerCheck ↗SEC IAPD adviser search ↗

Business registries

California Secretary of State business search ↗OpenCorporates ↗

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Maha Katabi appears on a new Form D, or when a court case or SEC action is matched to them. See plans →